Healthcare Market Research Reports and Trends

The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market. The  lung stent market  is projected to reach $120 million by 2024 from $87 million in 2019, at a CAGR of 6.7%. Market Dynamics + Drivers  + Rising Prevalence of Lung Cancer and Respiratory Diseases + Increasing Preference for Minimally Invasive Procedures + Continuous Growth in the Healthcare Industry + Increasing Life Expectancy + Rising Healthcare Expenditure + Growing Geriatric Population Request for Free Sample Pages –  https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890 The market is segmented based on the type, material, product, end user, and re

Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. The  overall cardiac surgery instruments market  is expected to reach $1.63 Billion by 2022 from $1.16 Billion in 2017 at a CAGR of 7.1%.  North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. Followed by North America, Europe dominated the global market in 2017. The European market is mainly driven by increasing adoption of su

Factors contributing to the growth of this market include the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology ; and the increasing use of cold plasma in meat and poultry packaging decontamination. The surface treatment segment accounted for the largest share of the cold plasma market for the polymer and plastic industry. This market segment is majorly driven by the advantages of cold plasma surface treatment, such as increased durability, better hydrophobic properties, higher packing density, better film quality, enhanced coating surface smoothness, and lower cost. Download Sample Pages The benefits of cold plasma technology in wound healing applications—faster healing and better results, sterilization efficiency, & cost-effectiveness as compared to conventional methods Some Key Players Nordson Corporation (U.S.), Bovie Medical Corporation (US), ADT

Growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent. Imaging systems, sperm separation systems, cabinets (workstations), ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, gas analyzers, laser analyzers, anti-vibration tables, accessories, and witness systems. However, sperm separation systems are expected to witness the highest growth, due to factors such as the rising use of donated sperm in IVF procedures. Sample Pages The global IVF market has been segmented into fertility clinics and surgical centers, hospitals and research laboratories, and cryobanks. The fertility clinics and surgical centers

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment. The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the companion diagnostics market. What is growth in  Companion Diagnostics  Market ? The  global companion diagnostics market  is expected to reach $6.51 billion by 2022 from $2.17 billion in 2016, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. Rising adoption of companion diagnostics assay kits & reagents in major appl

Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. Rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. What is growth in Immunohistochemistry Market   ? The  global immunohistochemistry market  is projected to reach $2.12 billion by 2021, at a CAGR of 7.3%. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. Objectives of the study: To define, describe, and forecast the global immunohistochemistry market on the basis of product, application, and end user To provide detailed information

Increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. Growing initiatives undertaken by leading market players (such as GE Healthcare, Philips Healthcare, and Siemens Healthineers) to establish refurbishment facilities in both mature and developing markets are further adding to the growth prospects of Refurbished Medical Equipment market. What is growth in Refurbished Medical Equipment Market   ? The  global refurbished medical equipment market  is expected to reach $11.91 Billion by 2021 from $6.55 Billion in 2016, at a CAGR of 12.7%. What are segments in Refurbished Medical Equipment Market ? The medical imaging equipment segment holds the largest share of the global refurbished medical equipment market in 2016. Most healthcare facil

Dental imaging is performed at the dental clinics and dental laboratories for the diagnosis, prevention, and treatment of oral health diseases. This market is driven by several factors which include technological advancements, increasing aging populations, rising awareness and increasing disposable income in emerging economies,growing demand for cosmetic dentistry, and shift towards advanced digital dental imaging systems. What is growth in Dental Imaging Market ? The  g lobal  dental imaging market  is expected to reach $2,686.5million by 2019 from $1,691.1million in 2014, growing at a CAGR of 9.7% from 2014 to 2019.  What are segments in Dental Imaging Market ? The dental imaging market is segmented into X-ray systems, dental CBCT, intraoral cameras and dental optical imaging. In 2014, the X-ray systems segment is expected to account for the largest share of the global market, by technology. The high share can be attributed to the extensive use of X-Ray systems for essentia

The growth of the market is primarily driven by factors such as growth in the target patient population, rising adoption of minimally invasive surgical procedures, and the increasing number of microcatheter-assisted clinical research studies. Microcatheters Market Growth :- The  global microcatheters market  is projected to reach USD 924 Million by 2024 from USD 688 Million in 2018. The market is expected to grow at a CAGR of 5.0% from 2018 to 2024. Microcatheters Market – Product :- Based on product type, the market is segmented into delivery microcatheters, aspiration microcatheters, diagnostic microcatheters, and steerable microcatheters. The steerable microcatheters segment is expected to grow at the highest CAGR during the forecast period (2018-2024). The high growth of this segment is attributed to the growing number of image-guided and minimally invasive medical procedures across major countries, shift from manually operated devices towards robotically operated surgical p

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Ligation Devices Market Growth The  Global ligation devices market  is projected to reach $1,189 million by 2024 from $876 million in 2019, at a CAGR of 6.3%. Download PDF Brochures –  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22007372 Accessories – Ligation Devices The market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. Applications – Ligation Devices The market is segmented into gastrointestinal & abdominal surgeries, gynecologica

The growth of the pharmaceutical R&D expenditure is expected to be one of the major factors driving the growth of this market during the forecast period. Moreover, the collaborative application of nanotechnology and track etching is expected to increase the adoption of Track etched Membranes in various applications, such as healthcare, fuel cells, telecommunications, and transportation Ask for Expert Advice -  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42556211 Early buyers will receive 10% customization on this report  According to a new market research report " Track etched Membrane Market  by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 813.1 million by 2023 from USD 476.0 million in 2018, at a CAGR of

Growth in this market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men. What is Medical Aesthetics? Medical aesthetics  is a method that utilizes minimal invasive treatments that aid to improve the physical appearance of a person with the use of beauty services and  healthcare  along with laser or any other energy-based device. There are abundant factors that is propelling the growth of the  medical aesthetics market . The  medical aesthetics market  is projected to reach $17.07 billion by 2023 from $10.30 billion in 2018, at a CAGR of 10.6%. Medical Aesthetics : Segments  The global medical aesthetics market is segmented on the basis of product, end user, and region. On the basis of produc

According to the new market research report " Apoptosis Assays Market  by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) - Global Forecast to 2023", published by MarketsandMarkets™, The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%. Don’t miss out on business opportunities in Apoptosis Assays Market. Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=9069428 This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strate